Global IV Solutions Market Growth 2026-2032
The global IV Solutions market size is predicted to grow from US$ 13531 million in 2025 to US$ 21215 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.
In 2025, the global production of IV solutions reached approximately 1.383 billion liters, with an average global market price of around US$10/L. In the same year, the global total production capacity of IV solutions reached 1.728 billion liters. The industry average gross profit margin of this product reached 31%.IV Solutions refer to sterile liquid preparations administered intravenously directly into the human circulatory system. They are primarily used for replenishing fluids, electrolytes, nutrients, blood volume, and delivering drugs. Products are typically packaged in glass bottles, plastic bottles, or soft bags and must meet sterility, pyrogen-free, particulate matter control, and pharmacopoeia standards. Common products include 0.9% sodium chloride injection, glucose injection, lactated Ringer's solution, compound electrolyte solutions, parenteral nutrition solutions (TPN), amino acid infusions, and fat emulsion infusions, widely used in clinical settings such as emergency care, perioperative care, intensive care, cancer treatment, dialysis, and long-term nutritional support.
The upstream of the IV Solutions industry chain mainly includes active pharmaceutical ingredients (APIs), water for injection, packaging materials, and production equipment; the midstream consists of infusion preparation manufacturers responsible for formulation development, aseptic production, quality control, and registration certification; the downstream encompasses hospitals, clinics, emergency centers, hemodialysis centers, home infusion facilities, and pharmaceutical distributors. With an aging population, increasing chronic diseases, and growing demand for home care, downstream applications are gradually expanding from traditional hospitals to home healthcare and specialized infusion centers.
IV solutions are among the essential medications in the global healthcare system, with strong market demand. Future growth will primarily come from an aging population, an increase in cancer and chronic disease patients, increased surgical volume, growing demand for intensive care, and the widespread adoption of home-based intravenous infusion therapy. Simultaneously, the proportion of high-value-added products such as parenteral nutrition (TPN), fat emulsions, specialized electrolyte formulas, and immunonutritional infusions continues to rise, driving the industry's upgrade from traditional fluid replacement to precision nutritional support and specialized treatment. Improved healthcare infrastructure and hospital expansion in developing countries will also bring new market growth; therefore, the global intravenous infusion solutions market is expected to maintain medium-to-high-speed growth in the coming years.
United States market for IV Solutions is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for IV Solutions is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for IV Solutions is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key IV Solutions players cover Baxter, Kelun Group, Fresenius Kabi, Otsuka, ICU Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?IV Solutions Industry Forecast? looks at past sales and reviews total world IV Solutions sales in 2025, providing a comprehensive analysis by region and market sector of projected IV Solutions sales for 2026 through 2032. With IV Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IV Solutions industry.
This Insight Report provides a comprehensive analysis of the global IV Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IV Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global IV Solutions market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IV Solutions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IV Solutions.
This report presents a comprehensive overview, market shares, and growth opportunities of IV Solutions market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global IV Solutions market?
What factors are driving IV Solutions market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IV Solutions market opportunities vary by end market size?
How does IV Solutions break out by Type, by Application?
In 2025, the global production of IV solutions reached approximately 1.383 billion liters, with an average global market price of around US$10/L. In the same year, the global total production capacity of IV solutions reached 1.728 billion liters. The industry average gross profit margin of this product reached 31%.IV Solutions refer to sterile liquid preparations administered intravenously directly into the human circulatory system. They are primarily used for replenishing fluids, electrolytes, nutrients, blood volume, and delivering drugs. Products are typically packaged in glass bottles, plastic bottles, or soft bags and must meet sterility, pyrogen-free, particulate matter control, and pharmacopoeia standards. Common products include 0.9% sodium chloride injection, glucose injection, lactated Ringer's solution, compound electrolyte solutions, parenteral nutrition solutions (TPN), amino acid infusions, and fat emulsion infusions, widely used in clinical settings such as emergency care, perioperative care, intensive care, cancer treatment, dialysis, and long-term nutritional support.
The upstream of the IV Solutions industry chain mainly includes active pharmaceutical ingredients (APIs), water for injection, packaging materials, and production equipment; the midstream consists of infusion preparation manufacturers responsible for formulation development, aseptic production, quality control, and registration certification; the downstream encompasses hospitals, clinics, emergency centers, hemodialysis centers, home infusion facilities, and pharmaceutical distributors. With an aging population, increasing chronic diseases, and growing demand for home care, downstream applications are gradually expanding from traditional hospitals to home healthcare and specialized infusion centers.
IV solutions are among the essential medications in the global healthcare system, with strong market demand. Future growth will primarily come from an aging population, an increase in cancer and chronic disease patients, increased surgical volume, growing demand for intensive care, and the widespread adoption of home-based intravenous infusion therapy. Simultaneously, the proportion of high-value-added products such as parenteral nutrition (TPN), fat emulsions, specialized electrolyte formulas, and immunonutritional infusions continues to rise, driving the industry's upgrade from traditional fluid replacement to precision nutritional support and specialized treatment. Improved healthcare infrastructure and hospital expansion in developing countries will also bring new market growth; therefore, the global intravenous infusion solutions market is expected to maintain medium-to-high-speed growth in the coming years.
United States market for IV Solutions is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for IV Solutions is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for IV Solutions is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key IV Solutions players cover Baxter, Kelun Group, Fresenius Kabi, Otsuka, ICU Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?IV Solutions Industry Forecast? looks at past sales and reviews total world IV Solutions sales in 2025, providing a comprehensive analysis by region and market sector of projected IV Solutions sales for 2026 through 2032. With IV Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IV Solutions industry.
This Insight Report provides a comprehensive analysis of the global IV Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IV Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global IV Solutions market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IV Solutions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IV Solutions.
This report presents a comprehensive overview, market shares, and growth opportunities of IV Solutions market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Basic Fluid Replacement Infusion
- Electrolyte Balance Infusion
- Nutritional Infusion
- Special Therapeutic Infusion
- Glass Bottle Infusion
- PP Plastic Bottle Infusion
- Non-PVC Soft Bag Infusion
- Small Volume Infusion (<100ml)
- Medium Volume Infusion (100-500ml)
- Large Volume Infusion (>500ml)
- Hospitals
- Clinics
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Baxter
- Kelun Group
- Fresenius Kabi
- Otsuka
- ICU Medical
- B. Braun Melsungen
- JW Life Science
- Shijiazhuang No.4 Pharmaceutical
- CR Double-Crane Pharmaceutical
- Sichuan Yuanda Shuyang Pharmaceutical
- Beximco Pharmaceuticals
- PT Otsuka Indonesia
- Pharma Impex Laboratories
- Fuso Pharmaceutical Industries
- Dai Han Pharm
What is the 10-year outlook for the global IV Solutions market?
What factors are driving IV Solutions market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IV Solutions market opportunities vary by end market size?
How does IV Solutions break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IV Solutions Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for IV Solutions by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for IV Solutions by Country/Region, 2021, 2025 & 2032
2.2 IV Solutions Segment by Type
2.2.1 Basic Fluid Replacement Infusion
2.2.2 Electrolyte Balance Infusion
2.2.3 Nutritional Infusion
2.2.4 Special Therapeutic Infusion
2.2.5 IV Solutions Sales by Type
2.2.5.1 Global IV Solutions Sales Market Share by Type (2021-2026)
2.2.5.2 Global IV Solutions Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global IV Solutions Sale Price by Type (2021-2026)
2.3 IV Solutions Segment by Packaging Form
2.3.1 Glass Bottle Infusion
2.3.2 PP Plastic Bottle Infusion
2.3.3 Non-PVC Soft Bag Infusion
2.3.4 IV Solutions Sales by Packaging Form
2.3.4.1 Global IV Solutions Sales Market Share by Packaging Form (2021-2026)
2.3.4.2 Global IV Solutions Revenue and Market Share by Packaging Form (2021-2026)
2.3.4.3 Global IV Solutions Sale Price by Packaging Form (2021-2026)
2.4 IV Solutions Segment by Volume
2.4.1 Small Volume Infusion (<100ml)
2.4.2 Medium Volume Infusion (100-500ml)
2.4.3 Large Volume Infusion (>500ml)
2.4.4 IV Solutions Sales by Volume
2.4.4.1 Global IV Solutions Sales Market Share by Volume (2021-2026)
2.4.4.2 Global IV Solutions Revenue and Market Share by Volume (2021-2026)
2.4.4.3 Global IV Solutions Sale Price by Volume (2021-2026)
2.5 IV Solutions Segment by Application
2.5.1 Hospitals
2.5.2 Clinics
2.5.3 Other
2.5.4 IV Solutions Sales by Application
2.5.4.1 Global IV Solutions Sale Market Share by Application (2021-2026)
2.5.4.2 Global IV Solutions Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global IV Solutions Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global IV Solutions Breakdown Data by Company
3.1.1 Global IV Solutions Annual Sales by Company (2021-2026)
3.1.2 Global IV Solutions Sales Market Share by Company (2021-2026)
3.2 Global IV Solutions Annual Revenue by Company (2021-2026)
3.2.1 Global IV Solutions Revenue by Company (2021-2026)
3.2.2 Global IV Solutions Revenue Market Share by Company (2021-2026)
3.3 Global IV Solutions Sale Price by Company
3.4 Key Manufacturers IV Solutions Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IV Solutions Product Location Distribution
3.4.2 Players IV Solutions Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IV SOLUTIONS BY GEOGRAPHIC REGION
4.1 World Historic IV Solutions Market Size by Geographic Region (2021-2026)
4.1.1 Global IV Solutions Annual Sales by Geographic Region (2021-2026)
4.1.2 Global IV Solutions Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic IV Solutions Market Size by Country/Region (2021-2026)
4.2.1 Global IV Solutions Annual Sales by Country/Region (2021-2026)
4.2.2 Global IV Solutions Annual Revenue by Country/Region (2021-2026)
4.3 Americas IV Solutions Sales Growth
4.4 APAC IV Solutions Sales Growth
4.5 Europe IV Solutions Sales Growth
4.6 Middle East & Africa IV Solutions Sales Growth
5 AMERICAS
5.1 Americas IV Solutions Sales by Country
5.1.1 Americas IV Solutions Sales by Country (2021-2026)
5.1.2 Americas IV Solutions Revenue by Country (2021-2026)
5.2 Americas IV Solutions Sales by Type (2021-2026)
5.3 Americas IV Solutions Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IV Solutions Sales by Region
6.1.1 APAC IV Solutions Sales by Region (2021-2026)
6.1.2 APAC IV Solutions Revenue by Region (2021-2026)
6.2 APAC IV Solutions Sales by Type (2021-2026)
6.3 APAC IV Solutions Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe IV Solutions by Country
7.1.1 Europe IV Solutions Sales by Country (2021-2026)
7.1.2 Europe IV Solutions Revenue by Country (2021-2026)
7.2 Europe IV Solutions Sales by Type (2021-2026)
7.3 Europe IV Solutions Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IV Solutions by Country
8.1.1 Middle East & Africa IV Solutions Sales by Country (2021-2026)
8.1.2 Middle East & Africa IV Solutions Revenue by Country (2021-2026)
8.2 Middle East & Africa IV Solutions Sales by Type (2021-2026)
8.3 Middle East & Africa IV Solutions Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IV Solutions
10.3 Manufacturing Process Analysis of IV Solutions
10.4 Industry Chain Structure of IV Solutions
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IV Solutions Distributors
11.3 IV Solutions Customer
12 WORLD FORECAST REVIEW FOR IV SOLUTIONS BY GEOGRAPHIC REGION
12.1 Global IV Solutions Market Size Forecast by Region
12.1.1 Global IV Solutions Forecast by Region (2027-2032)
12.1.2 Global IV Solutions Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global IV Solutions Forecast by Type (2027-2032)
12.7 Global IV Solutions Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter IV Solutions Product Portfolios and Specifications
13.1.3 Baxter IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 Kelun Group
13.2.1 Kelun Group Company Information
13.2.2 Kelun Group IV Solutions Product Portfolios and Specifications
13.2.3 Kelun Group IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Kelun Group Main Business Overview
13.2.5 Kelun Group Latest Developments
13.3 Fresenius Kabi
13.3.1 Fresenius Kabi Company Information
13.3.2 Fresenius Kabi IV Solutions Product Portfolios and Specifications
13.3.3 Fresenius Kabi IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Fresenius Kabi Main Business Overview
13.3.5 Fresenius Kabi Latest Developments
13.4 Otsuka
13.4.1 Otsuka Company Information
13.4.2 Otsuka IV Solutions Product Portfolios and Specifications
13.4.3 Otsuka IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Otsuka Main Business Overview
13.4.5 Otsuka Latest Developments
13.5 ICU Medical
13.5.1 ICU Medical Company Information
13.5.2 ICU Medical IV Solutions Product Portfolios and Specifications
13.5.3 ICU Medical IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 ICU Medical Main Business Overview
13.5.5 ICU Medical Latest Developments
13.6 B. Braun Melsungen
13.6.1 B. Braun Melsungen Company Information
13.6.2 B. Braun Melsungen IV Solutions Product Portfolios and Specifications
13.6.3 B. Braun Melsungen IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 B. Braun Melsungen Main Business Overview
13.6.5 B. Braun Melsungen Latest Developments
13.7 JW Life Science
13.7.1 JW Life Science Company Information
13.7.2 JW Life Science IV Solutions Product Portfolios and Specifications
13.7.3 JW Life Science IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 JW Life Science Main Business Overview
13.7.5 JW Life Science Latest Developments
13.8 Shijiazhuang No.4 Pharmaceutical
13.8.1 Shijiazhuang No.4 Pharmaceutical Company Information
13.8.2 Shijiazhuang No.4 Pharmaceutical IV Solutions Product Portfolios and Specifications
13.8.3 Shijiazhuang No.4 Pharmaceutical IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shijiazhuang No.4 Pharmaceutical Main Business Overview
13.8.5 Shijiazhuang No.4 Pharmaceutical Latest Developments
13.9 CR Double-Crane Pharmaceutical
13.9.1 CR Double-Crane Pharmaceutical Company Information
13.9.2 CR Double-Crane Pharmaceutical IV Solutions Product Portfolios and Specifications
13.9.3 CR Double-Crane Pharmaceutical IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CR Double-Crane Pharmaceutical Main Business Overview
13.9.5 CR Double-Crane Pharmaceutical Latest Developments
13.10 Sichuan Yuanda Shuyang Pharmaceutical
13.10.1 Sichuan Yuanda Shuyang Pharmaceutical Company Information
13.10.2 Sichuan Yuanda Shuyang Pharmaceutical IV Solutions Product Portfolios and Specifications
13.10.3 Sichuan Yuanda Shuyang Pharmaceutical IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sichuan Yuanda Shuyang Pharmaceutical Main Business Overview
13.10.5 Sichuan Yuanda Shuyang Pharmaceutical Latest Developments
13.11 Beximco Pharmaceuticals
13.11.1 Beximco Pharmaceuticals Company Information
13.11.2 Beximco Pharmaceuticals IV Solutions Product Portfolios and Specifications
13.11.3 Beximco Pharmaceuticals IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Beximco Pharmaceuticals Main Business Overview
13.11.5 Beximco Pharmaceuticals Latest Developments
13.12 PT Otsuka Indonesia
13.12.1 PT Otsuka Indonesia Company Information
13.12.2 PT Otsuka Indonesia IV Solutions Product Portfolios and Specifications
13.12.3 PT Otsuka Indonesia IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 PT Otsuka Indonesia Main Business Overview
13.12.5 PT Otsuka Indonesia Latest Developments
13.13 Pharma Impex Laboratories
13.13.1 Pharma Impex Laboratories Company Information
13.13.2 Pharma Impex Laboratories IV Solutions Product Portfolios and Specifications
13.13.3 Pharma Impex Laboratories IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Pharma Impex Laboratories Main Business Overview
13.13.5 Pharma Impex Laboratories Latest Developments
13.14 Fuso Pharmaceutical Industries
13.14.1 Fuso Pharmaceutical Industries Company Information
13.14.2 Fuso Pharmaceutical Industries IV Solutions Product Portfolios and Specifications
13.14.3 Fuso Pharmaceutical Industries IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Fuso Pharmaceutical Industries Main Business Overview
13.14.5 Fuso Pharmaceutical Industries Latest Developments
13.15 Dai Han Pharm
13.15.1 Dai Han Pharm Company Information
13.15.2 Dai Han Pharm IV Solutions Product Portfolios and Specifications
13.15.3 Dai Han Pharm IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Dai Han Pharm Main Business Overview
13.15.5 Dai Han Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IV Solutions Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for IV Solutions by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for IV Solutions by Country/Region, 2021, 2025 & 2032
2.2 IV Solutions Segment by Type
2.2.1 Basic Fluid Replacement Infusion
2.2.2 Electrolyte Balance Infusion
2.2.3 Nutritional Infusion
2.2.4 Special Therapeutic Infusion
2.2.5 IV Solutions Sales by Type
2.2.5.1 Global IV Solutions Sales Market Share by Type (2021-2026)
2.2.5.2 Global IV Solutions Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global IV Solutions Sale Price by Type (2021-2026)
2.3 IV Solutions Segment by Packaging Form
2.3.1 Glass Bottle Infusion
2.3.2 PP Plastic Bottle Infusion
2.3.3 Non-PVC Soft Bag Infusion
2.3.4 IV Solutions Sales by Packaging Form
2.3.4.1 Global IV Solutions Sales Market Share by Packaging Form (2021-2026)
2.3.4.2 Global IV Solutions Revenue and Market Share by Packaging Form (2021-2026)
2.3.4.3 Global IV Solutions Sale Price by Packaging Form (2021-2026)
2.4 IV Solutions Segment by Volume
2.4.1 Small Volume Infusion (<100ml)
2.4.2 Medium Volume Infusion (100-500ml)
2.4.3 Large Volume Infusion (>500ml)
2.4.4 IV Solutions Sales by Volume
2.4.4.1 Global IV Solutions Sales Market Share by Volume (2021-2026)
2.4.4.2 Global IV Solutions Revenue and Market Share by Volume (2021-2026)
2.4.4.3 Global IV Solutions Sale Price by Volume (2021-2026)
2.5 IV Solutions Segment by Application
2.5.1 Hospitals
2.5.2 Clinics
2.5.3 Other
2.5.4 IV Solutions Sales by Application
2.5.4.1 Global IV Solutions Sale Market Share by Application (2021-2026)
2.5.4.2 Global IV Solutions Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global IV Solutions Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global IV Solutions Breakdown Data by Company
3.1.1 Global IV Solutions Annual Sales by Company (2021-2026)
3.1.2 Global IV Solutions Sales Market Share by Company (2021-2026)
3.2 Global IV Solutions Annual Revenue by Company (2021-2026)
3.2.1 Global IV Solutions Revenue by Company (2021-2026)
3.2.2 Global IV Solutions Revenue Market Share by Company (2021-2026)
3.3 Global IV Solutions Sale Price by Company
3.4 Key Manufacturers IV Solutions Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IV Solutions Product Location Distribution
3.4.2 Players IV Solutions Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IV SOLUTIONS BY GEOGRAPHIC REGION
4.1 World Historic IV Solutions Market Size by Geographic Region (2021-2026)
4.1.1 Global IV Solutions Annual Sales by Geographic Region (2021-2026)
4.1.2 Global IV Solutions Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic IV Solutions Market Size by Country/Region (2021-2026)
4.2.1 Global IV Solutions Annual Sales by Country/Region (2021-2026)
4.2.2 Global IV Solutions Annual Revenue by Country/Region (2021-2026)
4.3 Americas IV Solutions Sales Growth
4.4 APAC IV Solutions Sales Growth
4.5 Europe IV Solutions Sales Growth
4.6 Middle East & Africa IV Solutions Sales Growth
5 AMERICAS
5.1 Americas IV Solutions Sales by Country
5.1.1 Americas IV Solutions Sales by Country (2021-2026)
5.1.2 Americas IV Solutions Revenue by Country (2021-2026)
5.2 Americas IV Solutions Sales by Type (2021-2026)
5.3 Americas IV Solutions Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IV Solutions Sales by Region
6.1.1 APAC IV Solutions Sales by Region (2021-2026)
6.1.2 APAC IV Solutions Revenue by Region (2021-2026)
6.2 APAC IV Solutions Sales by Type (2021-2026)
6.3 APAC IV Solutions Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe IV Solutions by Country
7.1.1 Europe IV Solutions Sales by Country (2021-2026)
7.1.2 Europe IV Solutions Revenue by Country (2021-2026)
7.2 Europe IV Solutions Sales by Type (2021-2026)
7.3 Europe IV Solutions Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IV Solutions by Country
8.1.1 Middle East & Africa IV Solutions Sales by Country (2021-2026)
8.1.2 Middle East & Africa IV Solutions Revenue by Country (2021-2026)
8.2 Middle East & Africa IV Solutions Sales by Type (2021-2026)
8.3 Middle East & Africa IV Solutions Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IV Solutions
10.3 Manufacturing Process Analysis of IV Solutions
10.4 Industry Chain Structure of IV Solutions
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IV Solutions Distributors
11.3 IV Solutions Customer
12 WORLD FORECAST REVIEW FOR IV SOLUTIONS BY GEOGRAPHIC REGION
12.1 Global IV Solutions Market Size Forecast by Region
12.1.1 Global IV Solutions Forecast by Region (2027-2032)
12.1.2 Global IV Solutions Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global IV Solutions Forecast by Type (2027-2032)
12.7 Global IV Solutions Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter IV Solutions Product Portfolios and Specifications
13.1.3 Baxter IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 Kelun Group
13.2.1 Kelun Group Company Information
13.2.2 Kelun Group IV Solutions Product Portfolios and Specifications
13.2.3 Kelun Group IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Kelun Group Main Business Overview
13.2.5 Kelun Group Latest Developments
13.3 Fresenius Kabi
13.3.1 Fresenius Kabi Company Information
13.3.2 Fresenius Kabi IV Solutions Product Portfolios and Specifications
13.3.3 Fresenius Kabi IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Fresenius Kabi Main Business Overview
13.3.5 Fresenius Kabi Latest Developments
13.4 Otsuka
13.4.1 Otsuka Company Information
13.4.2 Otsuka IV Solutions Product Portfolios and Specifications
13.4.3 Otsuka IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Otsuka Main Business Overview
13.4.5 Otsuka Latest Developments
13.5 ICU Medical
13.5.1 ICU Medical Company Information
13.5.2 ICU Medical IV Solutions Product Portfolios and Specifications
13.5.3 ICU Medical IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 ICU Medical Main Business Overview
13.5.5 ICU Medical Latest Developments
13.6 B. Braun Melsungen
13.6.1 B. Braun Melsungen Company Information
13.6.2 B. Braun Melsungen IV Solutions Product Portfolios and Specifications
13.6.3 B. Braun Melsungen IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 B. Braun Melsungen Main Business Overview
13.6.5 B. Braun Melsungen Latest Developments
13.7 JW Life Science
13.7.1 JW Life Science Company Information
13.7.2 JW Life Science IV Solutions Product Portfolios and Specifications
13.7.3 JW Life Science IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 JW Life Science Main Business Overview
13.7.5 JW Life Science Latest Developments
13.8 Shijiazhuang No.4 Pharmaceutical
13.8.1 Shijiazhuang No.4 Pharmaceutical Company Information
13.8.2 Shijiazhuang No.4 Pharmaceutical IV Solutions Product Portfolios and Specifications
13.8.3 Shijiazhuang No.4 Pharmaceutical IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shijiazhuang No.4 Pharmaceutical Main Business Overview
13.8.5 Shijiazhuang No.4 Pharmaceutical Latest Developments
13.9 CR Double-Crane Pharmaceutical
13.9.1 CR Double-Crane Pharmaceutical Company Information
13.9.2 CR Double-Crane Pharmaceutical IV Solutions Product Portfolios and Specifications
13.9.3 CR Double-Crane Pharmaceutical IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CR Double-Crane Pharmaceutical Main Business Overview
13.9.5 CR Double-Crane Pharmaceutical Latest Developments
13.10 Sichuan Yuanda Shuyang Pharmaceutical
13.10.1 Sichuan Yuanda Shuyang Pharmaceutical Company Information
13.10.2 Sichuan Yuanda Shuyang Pharmaceutical IV Solutions Product Portfolios and Specifications
13.10.3 Sichuan Yuanda Shuyang Pharmaceutical IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sichuan Yuanda Shuyang Pharmaceutical Main Business Overview
13.10.5 Sichuan Yuanda Shuyang Pharmaceutical Latest Developments
13.11 Beximco Pharmaceuticals
13.11.1 Beximco Pharmaceuticals Company Information
13.11.2 Beximco Pharmaceuticals IV Solutions Product Portfolios and Specifications
13.11.3 Beximco Pharmaceuticals IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Beximco Pharmaceuticals Main Business Overview
13.11.5 Beximco Pharmaceuticals Latest Developments
13.12 PT Otsuka Indonesia
13.12.1 PT Otsuka Indonesia Company Information
13.12.2 PT Otsuka Indonesia IV Solutions Product Portfolios and Specifications
13.12.3 PT Otsuka Indonesia IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 PT Otsuka Indonesia Main Business Overview
13.12.5 PT Otsuka Indonesia Latest Developments
13.13 Pharma Impex Laboratories
13.13.1 Pharma Impex Laboratories Company Information
13.13.2 Pharma Impex Laboratories IV Solutions Product Portfolios and Specifications
13.13.3 Pharma Impex Laboratories IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Pharma Impex Laboratories Main Business Overview
13.13.5 Pharma Impex Laboratories Latest Developments
13.14 Fuso Pharmaceutical Industries
13.14.1 Fuso Pharmaceutical Industries Company Information
13.14.2 Fuso Pharmaceutical Industries IV Solutions Product Portfolios and Specifications
13.14.3 Fuso Pharmaceutical Industries IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Fuso Pharmaceutical Industries Main Business Overview
13.14.5 Fuso Pharmaceutical Industries Latest Developments
13.15 Dai Han Pharm
13.15.1 Dai Han Pharm Company Information
13.15.2 Dai Han Pharm IV Solutions Product Portfolios and Specifications
13.15.3 Dai Han Pharm IV Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Dai Han Pharm Main Business Overview
13.15.5 Dai Han Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. IV Solutions Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. IV Solutions Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Basic Fluid Replacement Infusion
Table 4. Major Players of Electrolyte Balance Infusion
Table 5. Major Players of Nutritional Infusion
Table 6. Major Players of Special Therapeutic Infusion
Table 7. Global IV Solutions Sales by Type (2021-2026) & (L)
Table 8. Global IV Solutions Sales Market Share by Type (2021-2026)
Table 9. Global IV Solutions Revenue by Type (2021-2026) & ($ million)
Table 10. Global IV Solutions Revenue Market Share by Type (2021-2026)
Table 11. Global IV Solutions Sale Price by Type (2021-2026) & (US$/L)
Table 12. Major Players of Glass Bottle Infusion
Table 13. Major Players of PP Plastic Bottle Infusion
Table 14. Major Players of Non-PVC Soft Bag Infusion
Table 15. Global IV Solutions Sales by Packaging Form (2021-2026) & (L)
Table 16. Global IV Solutions Sales Market Share by Packaging Form (2021-2026)
Table 17. Global IV Solutions Revenue by Packaging Form (2021-2026) & ($ million)
Table 18. Global IV Solutions Revenue Market Share by Packaging Form (2021-2026)
Table 19. Global IV Solutions Sale Price by Packaging Form (2021-2026) & (US$/L)
Table 20. Major Players of Small Volume Infusion (<100ml)
Table 21. Major Players of Medium Volume Infusion (100-500ml)
Table 22. Major Players of Large Volume Infusion (>500ml)
Table 23. Global IV Solutions Sales by Volume (2021-2026) & (L)
Table 24. Global IV Solutions Sales Market Share by Volume (2021-2026)
Table 25. Global IV Solutions Revenue by Volume (2021-2026) & ($ million)
Table 26. Global IV Solutions Revenue Market Share by Volume (2021-2026)
Table 27. Global IV Solutions Sale Price by Volume (2021-2026) & (US$/L)
Table 28. Global IV Solutions Sale by Application (2021-2026) & (L)
Table 29. Global IV Solutions Sale Market Share by Application (2021-2026)
Table 30. Global IV Solutions Revenue by Application (2021-2026) & ($ million)
Table 31. Global IV Solutions Revenue Market Share by Application (2021-2026)
Table 32. Global IV Solutions Sale Price by Application (2021-2026) & (US$/L)
Table 33. Global IV Solutions Sales by Company (2021-2026) & (L)
Table 34. Global IV Solutions Sales Market Share by Company (2021-2026)
Table 35. Global IV Solutions Revenue by Company (2021-2026) & ($ millions)
Table 36. Global IV Solutions Revenue Market Share by Company (2021-2026)
Table 37. Global IV Solutions Sale Price by Company (2021-2026) & (US$/L)
Table 38. Key Manufacturers IV Solutions Producing Area Distribution and Sales Area
Table 39. Players IV Solutions Products Offered
Table 40. IV Solutions Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global IV Solutions Sales by Geographic Region (2021-2026) & (L)
Table 44. Global IV Solutions Sales Market Share Geographic Region (2021-2026)
Table 45. Global IV Solutions Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global IV Solutions Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global IV Solutions Sales by Country/Region (2021-2026) & (L)
Table 48. Global IV Solutions Sales Market Share by Country/Region (2021-2026)
Table 49. Global IV Solutions Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global IV Solutions Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas IV Solutions Sales by Country (2021-2026) & (L)
Table 52. Americas IV Solutions Sales Market Share by Country (2021-2026)
Table 53. Americas IV Solutions Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas IV Solutions Sales by Type (2021-2026) & (L)
Table 55. Americas IV Solutions Sales by Application (2021-2026) & (L)
Table 56. APAC IV Solutions Sales by Region (2021-2026) & (L)
Table 57. APAC IV Solutions Sales Market Share by Region (2021-2026)
Table 58. APAC IV Solutions Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC IV Solutions Sales by Type (2021-2026) & (L)
Table 60. APAC IV Solutions Sales by Application (2021-2026) & (L)
Table 61. Europe IV Solutions Sales by Country (2021-2026) & (L)
Table 62. Europe IV Solutions Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe IV Solutions Sales by Type (2021-2026) & (L)
Table 64. Europe IV Solutions Sales by Application (2021-2026) & (L)
Table 65. Middle East & Africa IV Solutions Sales by Country (2021-2026) & (L)
Table 66. Middle East & Africa IV Solutions Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa IV Solutions Sales by Type (2021-2026) & (L)
Table 68. Middle East & Africa IV Solutions Sales by Application (2021-2026) & (L)
Table 69. Key Market Drivers & Growth Opportunities of IV Solutions
Table 70. Key Market Challenges & Risks of IV Solutions
Table 71. Key Industry Trends of IV Solutions
Table 72. IV Solutions Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. IV Solutions Distributors List
Table 75. IV Solutions Customer List
Table 76. Global IV Solutions Sales Forecast by Region (2027-2032) & (L)
Table 77. Global IV Solutions Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas IV Solutions Sales Forecast by Country (2027-2032) & (L)
Table 79. Americas IV Solutions Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC IV Solutions Sales Forecast by Region (2027-2032) & (L)
Table 81. APAC IV Solutions Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe IV Solutions Sales Forecast by Country (2027-2032) & (L)
Table 83. Europe IV Solutions Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa IV Solutions Sales Forecast by Country (2027-2032) & (L)
Table 85. Middle East & Africa IV Solutions Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global IV Solutions Sales Forecast by Type (2027-2032) & (L)
Table 87. Global IV Solutions Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global IV Solutions Sales Forecast by Application (2027-2032) & (L)
Table 89. Global IV Solutions Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Baxter Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 91. Baxter IV Solutions Product Portfolios and Specifications
Table 92. Baxter IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 93. Baxter Main Business
Table 94. Baxter Latest Developments
Table 95. Kelun Group Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 96. Kelun Group IV Solutions Product Portfolios and Specifications
Table 97. Kelun Group IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 98. Kelun Group Main Business
Table 99. Kelun Group Latest Developments
Table 100. Fresenius Kabi Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 101. Fresenius Kabi IV Solutions Product Portfolios and Specifications
Table 102. Fresenius Kabi IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 103. Fresenius Kabi Main Business
Table 104. Fresenius Kabi Latest Developments
Table 105. Otsuka Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 106. Otsuka IV Solutions Product Portfolios and Specifications
Table 107. Otsuka IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 108. Otsuka Main Business
Table 109. Otsuka Latest Developments
Table 110. ICU Medical Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 111. ICU Medical IV Solutions Product Portfolios and Specifications
Table 112. ICU Medical IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 113. ICU Medical Main Business
Table 114. ICU Medical Latest Developments
Table 115. B. Braun Melsungen Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 116. B. Braun Melsungen IV Solutions Product Portfolios and Specifications
Table 117. B. Braun Melsungen IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 118. B. Braun Melsungen Main Business
Table 119. B. Braun Melsungen Latest Developments
Table 120. JW Life Science Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 121. JW Life Science IV Solutions Product Portfolios and Specifications
Table 122. JW Life Science IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 123. JW Life Science Main Business
Table 124. JW Life Science Latest Developments
Table 125. Shijiazhuang No.4 Pharmaceutical Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 126. Shijiazhuang No.4 Pharmaceutical IV Solutions Product Portfolios and Specifications
Table 127. Shijiazhuang No.4 Pharmaceutical IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 128. Shijiazhuang No.4 Pharmaceutical Main Business
Table 129. Shijiazhuang No.4 Pharmaceutical Latest Developments
Table 130. CR Double-Crane Pharmaceutical Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 131. CR Double-Crane Pharmaceutical IV Solutions Product Portfolios and Specifications
Table 132. CR Double-Crane Pharmaceutical IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 133. CR Double-Crane Pharmaceutical Main Business
Table 134. CR Double-Crane Pharmaceutical Latest Developments
Table 135. Sichuan Yuanda Shuyang Pharmaceutical Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 136. Sichuan Yuanda Shuyang Pharmaceutical IV Solutions Product Portfolios and Specifications
Table 137. Sichuan Yuanda Shuyang Pharmaceutical IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 138. Sichuan Yuanda Shuyang Pharmaceutical Main Business
Table 139. Sichuan Yuanda Shuyang Pharmaceutical Latest Developments
Table 140. Beximco Pharmaceuticals Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 141. Beximco Pharmaceuticals IV Solutions Product Portfolios and Specifications
Table 142. Beximco Pharmaceuticals IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 143. Beximco Pharmaceuticals Main Business
Table 144. Beximco Pharmaceuticals Latest Developments
Table 145. PT Otsuka Indonesia Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 146. PT Otsuka Indonesia IV Solutions Product Portfolios and Specifications
Table 147. PT Otsuka Indonesia IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 148. PT Otsuka Indonesia Main Business
Table 149. PT Otsuka Indonesia Latest Developments
Table 150. Pharma Impex Laboratories Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 151. Pharma Impex Laboratories IV Solutions Product Portfolios and Specifications
Table 152. Pharma Impex Laboratories IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 153. Pharma Impex Laboratories Main Business
Table 154. Pharma Impex Laboratories Latest Developments
Table 155. Fuso Pharmaceutical Industries Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 156. Fuso Pharmaceutical Industries IV Solutions Product Portfolios and Specifications
Table 157. Fuso Pharmaceutical Industries IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 158. Fuso Pharmaceutical Industries Main Business
Table 159. Fuso Pharmaceutical Industries Latest Developments
Table 160. Dai Han Pharm Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 161. Dai Han Pharm IV Solutions Product Portfolios and Specifications
Table 162. Dai Han Pharm IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 163. Dai Han Pharm Main Business
Table 164. Dai Han Pharm Latest Developments
Table 1. IV Solutions Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. IV Solutions Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Basic Fluid Replacement Infusion
Table 4. Major Players of Electrolyte Balance Infusion
Table 5. Major Players of Nutritional Infusion
Table 6. Major Players of Special Therapeutic Infusion
Table 7. Global IV Solutions Sales by Type (2021-2026) & (L)
Table 8. Global IV Solutions Sales Market Share by Type (2021-2026)
Table 9. Global IV Solutions Revenue by Type (2021-2026) & ($ million)
Table 10. Global IV Solutions Revenue Market Share by Type (2021-2026)
Table 11. Global IV Solutions Sale Price by Type (2021-2026) & (US$/L)
Table 12. Major Players of Glass Bottle Infusion
Table 13. Major Players of PP Plastic Bottle Infusion
Table 14. Major Players of Non-PVC Soft Bag Infusion
Table 15. Global IV Solutions Sales by Packaging Form (2021-2026) & (L)
Table 16. Global IV Solutions Sales Market Share by Packaging Form (2021-2026)
Table 17. Global IV Solutions Revenue by Packaging Form (2021-2026) & ($ million)
Table 18. Global IV Solutions Revenue Market Share by Packaging Form (2021-2026)
Table 19. Global IV Solutions Sale Price by Packaging Form (2021-2026) & (US$/L)
Table 20. Major Players of Small Volume Infusion (<100ml)
Table 21. Major Players of Medium Volume Infusion (100-500ml)
Table 22. Major Players of Large Volume Infusion (>500ml)
Table 23. Global IV Solutions Sales by Volume (2021-2026) & (L)
Table 24. Global IV Solutions Sales Market Share by Volume (2021-2026)
Table 25. Global IV Solutions Revenue by Volume (2021-2026) & ($ million)
Table 26. Global IV Solutions Revenue Market Share by Volume (2021-2026)
Table 27. Global IV Solutions Sale Price by Volume (2021-2026) & (US$/L)
Table 28. Global IV Solutions Sale by Application (2021-2026) & (L)
Table 29. Global IV Solutions Sale Market Share by Application (2021-2026)
Table 30. Global IV Solutions Revenue by Application (2021-2026) & ($ million)
Table 31. Global IV Solutions Revenue Market Share by Application (2021-2026)
Table 32. Global IV Solutions Sale Price by Application (2021-2026) & (US$/L)
Table 33. Global IV Solutions Sales by Company (2021-2026) & (L)
Table 34. Global IV Solutions Sales Market Share by Company (2021-2026)
Table 35. Global IV Solutions Revenue by Company (2021-2026) & ($ millions)
Table 36. Global IV Solutions Revenue Market Share by Company (2021-2026)
Table 37. Global IV Solutions Sale Price by Company (2021-2026) & (US$/L)
Table 38. Key Manufacturers IV Solutions Producing Area Distribution and Sales Area
Table 39. Players IV Solutions Products Offered
Table 40. IV Solutions Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global IV Solutions Sales by Geographic Region (2021-2026) & (L)
Table 44. Global IV Solutions Sales Market Share Geographic Region (2021-2026)
Table 45. Global IV Solutions Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global IV Solutions Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global IV Solutions Sales by Country/Region (2021-2026) & (L)
Table 48. Global IV Solutions Sales Market Share by Country/Region (2021-2026)
Table 49. Global IV Solutions Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global IV Solutions Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas IV Solutions Sales by Country (2021-2026) & (L)
Table 52. Americas IV Solutions Sales Market Share by Country (2021-2026)
Table 53. Americas IV Solutions Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas IV Solutions Sales by Type (2021-2026) & (L)
Table 55. Americas IV Solutions Sales by Application (2021-2026) & (L)
Table 56. APAC IV Solutions Sales by Region (2021-2026) & (L)
Table 57. APAC IV Solutions Sales Market Share by Region (2021-2026)
Table 58. APAC IV Solutions Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC IV Solutions Sales by Type (2021-2026) & (L)
Table 60. APAC IV Solutions Sales by Application (2021-2026) & (L)
Table 61. Europe IV Solutions Sales by Country (2021-2026) & (L)
Table 62. Europe IV Solutions Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe IV Solutions Sales by Type (2021-2026) & (L)
Table 64. Europe IV Solutions Sales by Application (2021-2026) & (L)
Table 65. Middle East & Africa IV Solutions Sales by Country (2021-2026) & (L)
Table 66. Middle East & Africa IV Solutions Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa IV Solutions Sales by Type (2021-2026) & (L)
Table 68. Middle East & Africa IV Solutions Sales by Application (2021-2026) & (L)
Table 69. Key Market Drivers & Growth Opportunities of IV Solutions
Table 70. Key Market Challenges & Risks of IV Solutions
Table 71. Key Industry Trends of IV Solutions
Table 72. IV Solutions Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. IV Solutions Distributors List
Table 75. IV Solutions Customer List
Table 76. Global IV Solutions Sales Forecast by Region (2027-2032) & (L)
Table 77. Global IV Solutions Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas IV Solutions Sales Forecast by Country (2027-2032) & (L)
Table 79. Americas IV Solutions Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC IV Solutions Sales Forecast by Region (2027-2032) & (L)
Table 81. APAC IV Solutions Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe IV Solutions Sales Forecast by Country (2027-2032) & (L)
Table 83. Europe IV Solutions Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa IV Solutions Sales Forecast by Country (2027-2032) & (L)
Table 85. Middle East & Africa IV Solutions Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global IV Solutions Sales Forecast by Type (2027-2032) & (L)
Table 87. Global IV Solutions Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global IV Solutions Sales Forecast by Application (2027-2032) & (L)
Table 89. Global IV Solutions Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Baxter Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 91. Baxter IV Solutions Product Portfolios and Specifications
Table 92. Baxter IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 93. Baxter Main Business
Table 94. Baxter Latest Developments
Table 95. Kelun Group Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 96. Kelun Group IV Solutions Product Portfolios and Specifications
Table 97. Kelun Group IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 98. Kelun Group Main Business
Table 99. Kelun Group Latest Developments
Table 100. Fresenius Kabi Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 101. Fresenius Kabi IV Solutions Product Portfolios and Specifications
Table 102. Fresenius Kabi IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 103. Fresenius Kabi Main Business
Table 104. Fresenius Kabi Latest Developments
Table 105. Otsuka Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 106. Otsuka IV Solutions Product Portfolios and Specifications
Table 107. Otsuka IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 108. Otsuka Main Business
Table 109. Otsuka Latest Developments
Table 110. ICU Medical Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 111. ICU Medical IV Solutions Product Portfolios and Specifications
Table 112. ICU Medical IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 113. ICU Medical Main Business
Table 114. ICU Medical Latest Developments
Table 115. B. Braun Melsungen Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 116. B. Braun Melsungen IV Solutions Product Portfolios and Specifications
Table 117. B. Braun Melsungen IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 118. B. Braun Melsungen Main Business
Table 119. B. Braun Melsungen Latest Developments
Table 120. JW Life Science Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 121. JW Life Science IV Solutions Product Portfolios and Specifications
Table 122. JW Life Science IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 123. JW Life Science Main Business
Table 124. JW Life Science Latest Developments
Table 125. Shijiazhuang No.4 Pharmaceutical Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 126. Shijiazhuang No.4 Pharmaceutical IV Solutions Product Portfolios and Specifications
Table 127. Shijiazhuang No.4 Pharmaceutical IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 128. Shijiazhuang No.4 Pharmaceutical Main Business
Table 129. Shijiazhuang No.4 Pharmaceutical Latest Developments
Table 130. CR Double-Crane Pharmaceutical Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 131. CR Double-Crane Pharmaceutical IV Solutions Product Portfolios and Specifications
Table 132. CR Double-Crane Pharmaceutical IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 133. CR Double-Crane Pharmaceutical Main Business
Table 134. CR Double-Crane Pharmaceutical Latest Developments
Table 135. Sichuan Yuanda Shuyang Pharmaceutical Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 136. Sichuan Yuanda Shuyang Pharmaceutical IV Solutions Product Portfolios and Specifications
Table 137. Sichuan Yuanda Shuyang Pharmaceutical IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 138. Sichuan Yuanda Shuyang Pharmaceutical Main Business
Table 139. Sichuan Yuanda Shuyang Pharmaceutical Latest Developments
Table 140. Beximco Pharmaceuticals Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 141. Beximco Pharmaceuticals IV Solutions Product Portfolios and Specifications
Table 142. Beximco Pharmaceuticals IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 143. Beximco Pharmaceuticals Main Business
Table 144. Beximco Pharmaceuticals Latest Developments
Table 145. PT Otsuka Indonesia Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 146. PT Otsuka Indonesia IV Solutions Product Portfolios and Specifications
Table 147. PT Otsuka Indonesia IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 148. PT Otsuka Indonesia Main Business
Table 149. PT Otsuka Indonesia Latest Developments
Table 150. Pharma Impex Laboratories Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 151. Pharma Impex Laboratories IV Solutions Product Portfolios and Specifications
Table 152. Pharma Impex Laboratories IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 153. Pharma Impex Laboratories Main Business
Table 154. Pharma Impex Laboratories Latest Developments
Table 155. Fuso Pharmaceutical Industries Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 156. Fuso Pharmaceutical Industries IV Solutions Product Portfolios and Specifications
Table 157. Fuso Pharmaceutical Industries IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 158. Fuso Pharmaceutical Industries Main Business
Table 159. Fuso Pharmaceutical Industries Latest Developments
Table 160. Dai Han Pharm Basic Information, IV Solutions Manufacturing Base, Sales Area and Its Competitors
Table 161. Dai Han Pharm IV Solutions Product Portfolios and Specifications
Table 162. Dai Han Pharm IV Solutions Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 163. Dai Han Pharm Main Business
Table 164. Dai Han Pharm Latest Developments
LIST OF FIGURES
Figure 1. Picture of IV Solutions
Figure 2. IV Solutions Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IV Solutions Sales Growth Rate 2021-2032 (L)
Figure 7. Global IV Solutions Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. IV Solutions Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. IV Solutions Sales Market Share by Country/Region (2025)
Figure 10. IV Solutions Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Basic Fluid Replacement Infusion
Figure 12. Product Picture of Electrolyte Balance Infusion
Figure 13. Product Picture of Nutritional Infusion
Figure 14. Product Picture of Special Therapeutic Infusion
Figure 15. Global IV Solutions Sales Market Share by Type in 2026
Figure 16. Global IV Solutions Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Glass Bottle Infusion
Figure 18. Product Picture of PP Plastic Bottle Infusion
Figure 19. Product Picture of Non-PVC Soft Bag Infusion
Figure 20. Global IV Solutions Sales Market Share by Packaging Form in 2026
Figure 21. Global IV Solutions Revenue Market Share by Packaging Form (2021-2026)
Figure 22. Product Picture of Small Volume Infusion (<100ml)
Figure 23. Product Picture of Medium Volume Infusion (100-500ml)
Figure 24. Product Picture of Large Volume Infusion (>500ml)
Figure 25. Global IV Solutions Sales Market Share by Volume in 2026
Figure 26. Global IV Solutions Revenue Market Share by Volume (2021-2026)
Figure 27. IV Solutions Consumed in Hospitals
Figure 28. Global IV Solutions Market: Hospitals (2021-2026) & (L)
Figure 29. IV Solutions Consumed in Clinics
Figure 30. Global IV Solutions Market: Clinics (2021-2026) & (L)
Figure 31. IV Solutions Consumed in Other
Figure 32. Global IV Solutions Market: Other (2021-2026) & (L)
Figure 33. Global IV Solutions Sale Market Share by Application (2025)
Figure 34. Global IV Solutions Revenue Market Share by Application in 2025
Figure 35. IV Solutions Sales by Company in 2025 (L)
Figure 36. Global IV Solutions Sales Market Share by Company in 2025
Figure 37. IV Solutions Revenue by Company in 2025 ($ millions)
Figure 38. Global IV Solutions Revenue Market Share by Company in 2025
Figure 39. Global IV Solutions Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global IV Solutions Revenue Market Share by Geographic Region in 2025
Figure 41. Americas IV Solutions Sales 2021-2026 (L)
Figure 42. Americas IV Solutions Revenue 2021-2026 ($ millions)
Figure 43. APAC IV Solutions Sales 2021-2026 (L)
Figure 44. APAC IV Solutions Revenue 2021-2026 ($ millions)
Figure 45. Europe IV Solutions Sales 2021-2026 (L)
Figure 46. Europe IV Solutions Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa IV Solutions Sales 2021-2026 (L)
Figure 48. Middle East & Africa IV Solutions Revenue 2021-2026 ($ millions)
Figure 49. Americas IV Solutions Sales Market Share by Country in 2025
Figure 50. Americas IV Solutions Revenue Market Share by Country (2021-2026)
Figure 51. Americas IV Solutions Sales Market Share by Type (2021-2026)
Figure 52. Americas IV Solutions Sales Market Share by Application (2021-2026)
Figure 53. United States IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC IV Solutions Sales Market Share by Region in 2025
Figure 58. APAC IV Solutions Revenue Market Share by Region (2021-2026)
Figure 59. APAC IV Solutions Sales Market Share by Type (2021-2026)
Figure 60. APAC IV Solutions Sales Market Share by Application (2021-2026)
Figure 61. China IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 65. India IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe IV Solutions Sales Market Share by Country in 2025
Figure 69. Europe IV Solutions Revenue Market Share by Country (2021-2026)
Figure 70. Europe IV Solutions Sales Market Share by Type (2021-2026)
Figure 71. Europe IV Solutions Sales Market Share by Application (2021-2026)
Figure 72. Germany IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 73. France IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 74. UK IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa IV Solutions Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa IV Solutions Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa IV Solutions Sales Market Share by Application (2021-2026)
Figure 80. Egypt IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of IV Solutions in 2026
Figure 86. Manufacturing Process Analysis of IV Solutions
Figure 87. Industry Chain Structure of IV Solutions
Figure 88. Channels of Distribution
Figure 89. Global IV Solutions Sales Market Forecast by Region (2027-2032)
Figure 90. Global IV Solutions Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global IV Solutions Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global IV Solutions Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global IV Solutions Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global IV Solutions Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of IV Solutions
Figure 2. IV Solutions Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IV Solutions Sales Growth Rate 2021-2032 (L)
Figure 7. Global IV Solutions Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. IV Solutions Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. IV Solutions Sales Market Share by Country/Region (2025)
Figure 10. IV Solutions Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Basic Fluid Replacement Infusion
Figure 12. Product Picture of Electrolyte Balance Infusion
Figure 13. Product Picture of Nutritional Infusion
Figure 14. Product Picture of Special Therapeutic Infusion
Figure 15. Global IV Solutions Sales Market Share by Type in 2026
Figure 16. Global IV Solutions Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Glass Bottle Infusion
Figure 18. Product Picture of PP Plastic Bottle Infusion
Figure 19. Product Picture of Non-PVC Soft Bag Infusion
Figure 20. Global IV Solutions Sales Market Share by Packaging Form in 2026
Figure 21. Global IV Solutions Revenue Market Share by Packaging Form (2021-2026)
Figure 22. Product Picture of Small Volume Infusion (<100ml)
Figure 23. Product Picture of Medium Volume Infusion (100-500ml)
Figure 24. Product Picture of Large Volume Infusion (>500ml)
Figure 25. Global IV Solutions Sales Market Share by Volume in 2026
Figure 26. Global IV Solutions Revenue Market Share by Volume (2021-2026)
Figure 27. IV Solutions Consumed in Hospitals
Figure 28. Global IV Solutions Market: Hospitals (2021-2026) & (L)
Figure 29. IV Solutions Consumed in Clinics
Figure 30. Global IV Solutions Market: Clinics (2021-2026) & (L)
Figure 31. IV Solutions Consumed in Other
Figure 32. Global IV Solutions Market: Other (2021-2026) & (L)
Figure 33. Global IV Solutions Sale Market Share by Application (2025)
Figure 34. Global IV Solutions Revenue Market Share by Application in 2025
Figure 35. IV Solutions Sales by Company in 2025 (L)
Figure 36. Global IV Solutions Sales Market Share by Company in 2025
Figure 37. IV Solutions Revenue by Company in 2025 ($ millions)
Figure 38. Global IV Solutions Revenue Market Share by Company in 2025
Figure 39. Global IV Solutions Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global IV Solutions Revenue Market Share by Geographic Region in 2025
Figure 41. Americas IV Solutions Sales 2021-2026 (L)
Figure 42. Americas IV Solutions Revenue 2021-2026 ($ millions)
Figure 43. APAC IV Solutions Sales 2021-2026 (L)
Figure 44. APAC IV Solutions Revenue 2021-2026 ($ millions)
Figure 45. Europe IV Solutions Sales 2021-2026 (L)
Figure 46. Europe IV Solutions Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa IV Solutions Sales 2021-2026 (L)
Figure 48. Middle East & Africa IV Solutions Revenue 2021-2026 ($ millions)
Figure 49. Americas IV Solutions Sales Market Share by Country in 2025
Figure 50. Americas IV Solutions Revenue Market Share by Country (2021-2026)
Figure 51. Americas IV Solutions Sales Market Share by Type (2021-2026)
Figure 52. Americas IV Solutions Sales Market Share by Application (2021-2026)
Figure 53. United States IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC IV Solutions Sales Market Share by Region in 2025
Figure 58. APAC IV Solutions Revenue Market Share by Region (2021-2026)
Figure 59. APAC IV Solutions Sales Market Share by Type (2021-2026)
Figure 60. APAC IV Solutions Sales Market Share by Application (2021-2026)
Figure 61. China IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 65. India IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe IV Solutions Sales Market Share by Country in 2025
Figure 69. Europe IV Solutions Revenue Market Share by Country (2021-2026)
Figure 70. Europe IV Solutions Sales Market Share by Type (2021-2026)
Figure 71. Europe IV Solutions Sales Market Share by Application (2021-2026)
Figure 72. Germany IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 73. France IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 74. UK IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa IV Solutions Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa IV Solutions Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa IV Solutions Sales Market Share by Application (2021-2026)
Figure 80. Egypt IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries IV Solutions Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of IV Solutions in 2026
Figure 86. Manufacturing Process Analysis of IV Solutions
Figure 87. Industry Chain Structure of IV Solutions
Figure 88. Channels of Distribution
Figure 89. Global IV Solutions Sales Market Forecast by Region (2027-2032)
Figure 90. Global IV Solutions Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global IV Solutions Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global IV Solutions Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global IV Solutions Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global IV Solutions Revenue Market Share Forecast by Application (2027-2032)
